Economic Evaluations of Healthcare Programmes and Decision Making
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 23 (11), 1075-1082
- https://doi.org/10.2165/00019053-200523110-00002
Abstract
Given the potential role of economic information in healthcare decision making, it is of interest to assess its influence on decisions at a national or regional level (macro level), at a healthcare facility level (meso level) and at the healthcare provider level (micro level). This literature review summarises 36 empirical studies that examined the influence of economic evaluations on these three healthcare decision-making levels. Economic evaluations are considered useful and important; however, their direct influence on decision making (instrumental use) is moderate, especially at the macro and micro levels. A major influence was observed at the meso level, leading to the conclusion that economic evaluations have the most pronounced influence on decision making within healthcare organisations. However, unexpectedly, our literature search did not reveal an empirical study analysing the considerable influence of economic evaluations on decisions by the National Institute of Health and Clinical Excellence in the UK. Our findings indicate that results of economic evaluations cannot be considered the dominant decision criterion for healthcare decision makers at either the macro, meso or micro levels. Enlightenment use (where scientific evidence provides a background of information, ideas and concepts that affect the way policy makers view problems and solutions) of economic evaluations in decision making remains to be proven.Keywords
This publication has 40 references indexed in Scilit:
- The impact of economic information on medical decision making in primary careJournal of Evaluation in Clinical Practice, 2004
- Health care reform in six Central European countriesThe European Journal of Health Economics, 2003
- Ontario??s Formulary CommitteePharmacoEconomics, 2003
- USING EVIDENCE IN THE DEVELOPMENT OF LOCAL HEALTH POLICIESInternational Journal of Technology Assessment in Health Care, 2002
- Priority-setting decisions for new cancer drugs: a qualitative case studyThe Lancet, 2001
- Differences in Attitudes, Knowledge and Use of Economic Evaluations in Decision-Making in The NetherlandsPharmacoEconomics, 2000
- Pharmacoeconomics and Clinical Practice GuidelinesPharmacoEconomics, 2000
- Pharmaco‐economic information and its effect on prescriptionsJournal of Management in Medicine, 1996
- Economic Evaluation of Drugs and its Potential Uses in Policy MakingPharmacoEconomics, 1995
- The use of economic evaluation in health care: Australian decision makers' perceptionsHealth Policy, 1995